Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

ClinicalTrials.gov ID: NCT00154141

Public ClinicalTrials.gov record NCT00154141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 5:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or Upper Extremity Vascular Access Arterial Anastomosis

Study identification

NCT ID
NCT00154141
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ethicon, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Fibrin sealant (FS2) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Not listed
Completion
Feb 28, 2006
Last update posted
Jul 12, 2006

2005 – 2006

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Baptist Medical Center Jacksonville Florida 32216
Memorial Hospital Jacksonville Florida 32216
Jackson Memorial Hospital Miami Florida 33103
Southern Illinois University School of Medicine Springfield Illinois 62702
Iowa Heart Center Des Moines Iowa 50314
Univ of Mass Medical Center Worcester Massachusetts 01655
Hackensack Medical Center Hackensack New Jersey 07601
Alband Medical Center Albany New York 12208
Millarad Fillmore Hospital, SUNY Buffalo New York 14209
Jobst Vascular Center Toledo Ohio 43606
Vanderbilt Univ Medical Center Nashville Tennessee 37232
UVA Health System Charlottesville Virginia 22908
Vascular and Transplant Specialists Norfolk Virginia 23503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00154141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2006 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00154141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →